Clinical Trials Insight: 700051686
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2009
At a glance
- Drugs Elotuzumab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Sponsors Abbott Biotherapeutics Corp; Bristol-Myers Squibb
- 14 Dec 2009 New trial record.
- 07 Dec 2009 The anticipated trial initiation date is in the first half of 2010, according to a Bristol-Myers Squibb media release.